Water-soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7-nAChR dysfunction
- PMID: 32222974
- DOI: 10.1111/jnc.15018
Water-soluble variant of human Lynx1 positively modulates synaptic plasticity and ameliorates cognitive impairment associated with α7-nAChR dysfunction
Abstract
Lynx1 is a GPI-tethered protein colocalized with nicotinic acetylcholine receptors (nAChRs) in the brain areas important for learning and memory. Previously, we demonstrated that at low micromolar concentrations the water-soluble Lynx1 variant lacking GPI-anchor (ws-Lynx1) acts on α7-nAChRs as a positive allosteric modulator. We hypothesized that ws-Lynx1 could be used for improvement of cognitive processes dependent on nAChRs. Here we showed that 2 µM ws-Lynx1 increased the acetylcholine-evoked current at α7-nAChRs in the rat primary visual cortex L1 interneurons. At higher concentrations ws-Lynx1 inhibits α7-nAChRs expressed in Xenopus laevis oocytes with IC50 ~ 50 µM. In mice, ws-Lynx1 penetrated the blood-brain barrier upon intranasal administration and accumulated in the cortex, hippocampus, and cerebellum. Chronic ws-Lynx1 treatment prevented the olfactory memory and motor learning impairment induced by the α7-nAChRs inhibitor methyllycaconitine (MLA). Enhanced long-term potentiation and increased paired-pulse facilitation ratio were observed in the hippocampal slices incubated with ws-Lynx1 and in the slices from ws-Lynx1-treated mice. Long-term potentiation blockade observed in MLA-treated mice was abolished by ws-Lynx1 co-administration. To understand the mechanism of ws-Lynx1 action, we studied the interaction of ws-Lynx1 and MLA at α7-nAChRs, measured the basal concentrations of endogenous Lynx1 and the α7 nAChR subunit and their association in the mouse brain. Our findings suggest that endogenous Lynx1 limits α7-nAChRs activation in the adult brain. Ws-Lynx1 partially displaces Lynx1 causing positive modulation of α7-nAChRs and enhancement of synaptic plasticity. Ws-Lynx1 and similar compounds may constitute useful hits for treatment of cognitive deficits associated with the cholinergic system dysfunction.
Keywords: Ly6/uPAR; cognitive function; long-term potentiation; neurodegeneration; nicotinic acetylcholine receptor; positive allosteric modulator.
© 2020 International Society for Neurochemistry.
Similar articles
-
Water-soluble LYNX1 residues important for interaction with muscle-type and/or neuronal nicotinic receptors.J Biol Chem. 2013 May 31;288(22):15888-99. doi: 10.1074/jbc.M112.436576. Epub 2013 Apr 12. J Biol Chem. 2013. PMID: 23585571 Free PMC article.
-
Human Three-Finger Protein Lypd6 Is a Negative Modulator of the Cholinergic System in the Brain.Front Cell Dev Biol. 2021 Sep 21;9:662227. doi: 10.3389/fcell.2021.662227. eCollection 2021. Front Cell Dev Biol. 2021. PMID: 34631692 Free PMC article.
-
NMR structure and action on nicotinic acetylcholine receptors of water-soluble domain of human LYNX1.J Biol Chem. 2011 Mar 25;286(12):10618-27. doi: 10.1074/jbc.M110.189100. Epub 2011 Jan 20. J Biol Chem. 2011. PMID: 21252236 Free PMC article.
-
Three-finger proteins from snakes and humans acting on nicotinic receptors: Old and new.J Neurochem. 2021 Sep;158(6):1223-1235. doi: 10.1111/jnc.15123. Epub 2020 Jul 26. J Neurochem. 2021. PMID: 32648941 Review.
-
Lynx1 prototoxins: critical accessory proteins of neuronal nicotinic acetylcholine receptors.Curr Opin Pharmacol. 2021 Feb;56:46-51. doi: 10.1016/j.coph.2020.09.016. Epub 2020 Nov 27. Curr Opin Pharmacol. 2021. PMID: 33254061 Free PMC article. Review.
Cited by
-
Accumulation of β-Amyloid Leads to a Decrease in Lynx1 and Lypd6B Expression in the Hippocampus and Increased Expression of Proinflammatory Cytokines in the Hippocampus and Blood Serum.Dokl Biochem Biophys. 2023 Aug;511(1):145-150. doi: 10.1134/S1607672923700217. Epub 2023 Oct 13. Dokl Biochem Biophys. 2023. PMID: 37833597
-
Water-Soluble Lynx1 Upregulates Dendritic Spine Density and Stimulates Astrocytic Network and Signaling.Mol Neurobiol. 2024 Nov 20. doi: 10.1007/s12035-024-04627-1. Online ahead of print. Mol Neurobiol. 2024. PMID: 39565568
-
Orientational Preferences of GPI-Anchored Ly6/uPAR Proteins.Int J Mol Sci. 2022 Dec 20;24(1):11. doi: 10.3390/ijms24010011. Int J Mol Sci. 2022. PMID: 36613456 Free PMC article.
-
Expression and Roles of Lynx1, a Modulator of Cholinergic Transmission, in Skeletal Muscles and Neuromuscular Junctions in Mice.Front Cell Dev Biol. 2022 Mar 16;10:838612. doi: 10.3389/fcell.2022.838612. eCollection 2022. Front Cell Dev Biol. 2022. PMID: 35372356 Free PMC article.
-
Biophysical characterization of lynx-nicotinic receptor interactions using atomic force microscopy.FASEB Bioadv. 2021 Sep 14;3(12):1034-1042. doi: 10.1096/fba.2021-00012. eCollection 2021 Dec. FASEB Bioadv. 2021. PMID: 34938964 Free PMC article.
References
REFERENCES
-
- Andriambeloson, E., Huyard, B., Poiraud, E., & Wagner, S. (2014). Methyllycaconitine- and scopolamine-induced cognitive dysfunction: Differential reversal effect by cognition-enhancing drugs. Pharmacol Res Perspect, 2, e00048. https://doi.org/10.1002/prp2.48
-
- Barco, A., Alarcon, J. M., & Kandel, E. R. (2002). Expression of constitutively active CREB protein facilitates the late phase of long-term potentiation by enhancing synaptic capture. Cell, 108, 689-703. https://doi.org/10.1016/S0092-8674(02)00657-8
-
- Biton, B., Bergis, O. E., Galli, F., Nedelec, A., Lochead, A. W., Jegham, S., … Scatton, B. (2007). SSR180711, a novel selective alpha7 nicotinic receptor partial agonist: (1) binding and functional profile. Neuropsychopharmacology, 32, 1-16.
-
- Bychkov, M. L., Vasilyeva, N. A., Shulepko, M. A., Balaban, P. M., Kirpichnikov, M. P., & Lyukmanova, E. N. (2018). Lynx1 prevents long-term potentiation blockade and reduction of neuromodulator expression caused by Aβ1-42 and JNK activation. Acta Naturae, 3, 57-61. https://doi.org/10.32607/20758251-2018-10-3-57-61
-
- Cachelin, A. B., & Rust, G. (1994). Unusual pharmacology of (+)-tubocurarine with rat neuronal nicotinic acetylcholine receptors containing beta 4 subunits. Molecular Pharmacology, 46, 1168-1174.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources